CELLAMARE, Saverio
 Distribuzione geografica
Continente #
NA - Nord America 9.856
EU - Europa 3.282
AS - Asia 3.187
SA - Sud America 702
AF - Africa 92
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.128
Nazione #
US - Stati Uniti d'America 9.755
SG - Singapore 1.249
DE - Germania 1.104
CN - Cina 947
BR - Brasile 608
SE - Svezia 539
RU - Federazione Russa 459
HK - Hong Kong 398
IT - Italia 263
GB - Regno Unito 256
VN - Vietnam 233
UA - Ucraina 209
FI - Finlandia 162
FR - Francia 80
IN - India 78
CA - Canada 48
BE - Belgio 45
BD - Bangladesh 38
AR - Argentina 36
CI - Costa d'Avorio 35
ES - Italia 32
ID - Indonesia 32
MX - Messico 32
JP - Giappone 31
TR - Turchia 31
IQ - Iraq 28
IR - Iran 28
IE - Irlanda 26
NL - Olanda 23
PL - Polonia 22
ZA - Sudafrica 21
CZ - Repubblica Ceca 15
EC - Ecuador 15
AT - Austria 13
CO - Colombia 13
PK - Pakistan 11
LT - Lituania 10
KR - Corea 9
MA - Marocco 9
UZ - Uzbekistan 9
VE - Venezuela 9
SA - Arabia Saudita 8
CH - Svizzera 6
NP - Nepal 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
GE - Georgia 5
IL - Israele 5
OM - Oman 5
PE - Perù 5
PH - Filippine 5
AZ - Azerbaigian 4
DZ - Algeria 4
GT - Guatemala 4
KE - Kenya 4
MY - Malesia 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
GD - Grenada 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
PT - Portogallo 2
RO - Romania 2
SR - Suriname 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AN - Antille olandesi 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
MW - Malawi 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 17.124
Città #
Dallas 1.782
Fairfield 954
Chandler 764
Ashburn 745
Woodbridge 717
Singapore 637
Jacksonville 489
Houston 427
Hong Kong 388
Seattle 385
Nyköping 379
Wilmington 337
Ann Arbor 331
Cambridge 326
Beijing 255
Nanjing 160
Roxbury 151
Lawrence 146
Bari 118
Boardman 114
New York 113
Des Moines 95
Brooklyn 81
Princeton 79
Los Angeles 74
Dearborn 71
Ho Chi Minh City 66
Dong Ket 59
Munich 53
Nanchang 47
Hanoi 45
Jiaxing 45
Santa Clara 45
São Paulo 45
Brussels 44
Inglewood 43
Helsinki 39
Shenyang 39
San Diego 38
Hebei 36
Abidjan 35
London 33
Moscow 33
North Bergen 33
Buffalo 30
Council Bluffs 26
Dublin 26
Milan 26
Guangzhou 25
Tokyo 25
Montreal 22
Atlanta 20
Paris 20
Rio de Janeiro 20
Tianjin 20
Changsha 19
Jakarta 19
Belo Horizonte 18
Chicago 18
San Mateo 18
Warsaw 18
Washington 18
Brasília 17
Chennai 17
Marseille 17
Zhengzhou 17
Denver 16
Johannesburg 16
Shanghai 16
Frankfurt am Main 15
Leawood 15
Ningbo 15
Nuremberg 15
San Jose 15
Ardabil 14
West Jordan 14
Jinan 13
Kansas City 13
Manchester 13
Porto Alegre 13
Stockholm 13
Augusta 12
The Dalles 12
Boston 11
Columbus 11
Falkenstein 11
Toronto 11
Poplar 10
San Francisco 10
Amsterdam 9
Boydton 9
Brno 9
Dhaka 9
Mexico City 9
Norwalk 9
Orem 9
Tashkent 9
Curitiba 8
Haiphong 8
Hefei 8
Totale 11.752
Nome #
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.062
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships 1.054
Design, synthesis and biological evaluation of indane 2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as b-amyloid aggregation inhibitors 204
Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data 197
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 192
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile 185
A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease 181
Mind the Gap ! A Journey towards Computational Toxicology 176
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Aβ40 aggregation in vitro 171
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors 168
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 167
Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties 166
Repositioning of dantrolene for Alzheimer’s disease: new and old biological activities towards AD-related targets. 166
Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity 164
Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma 161
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 161
Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways 155
Exploring Basic Tail Modifications of Coumarin-based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-soluble, Brain-permeant Neuroprotective Multitarget Agents 155
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 152
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 151
Linear Solvation Energy Relationships in Reversed-Phase Liquid Chromatography. Examination of Deltabond C8 as Stationary Phase for Measuring Lipophilicity Parameters 150
Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 150
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 147
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4′-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase 146
3-benzazecine-based cyclic allene derivatives as highly potent P-glycoprotein inhibitors overcoming doxorubicin multidrug resistance 146
Partitioning behaviour of piracetam-type cognition enhancers 145
A novel strategy for the treatment of Hodgkin lymphoma 143
X-Ray Crystal Structure, Partitioning Behavior and Molecular Modeling Study of Piracetam-type Nootropics: Insights into the Pharmacophore 143
Design, synthesis, biological evaluation, NMR and DFT studies of structurally-simplified trimethoxy benzamides as P-glycoprotein selective inhibitors: the role of molecular flatness 143
Human mitochondrial carnitine acylcarnitine carrier: Molecular target of dietary bioactive polyphenols from sweet cherry (Prunus avium L.) 142
Molecular optimization of O-glycoside inhibitors of blood coagulation factors. 142
LFER and CoMFA studies on optical resolution of a-alkyl-a-aryloxyacetic acid methyl esters on DACH-DNB chiral stationary phase 140
Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding 138
Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6′-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N- methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors 136
Benzenesulfonamides Inhibitors of Carbonic Anhydrase: Study of Their Hydrophobicity by RPLC. QSAR: Quantitative Structure Activity Relationships 134
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 134
Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes 131
Annelated medium-sized azaheterocycles as attractive scaffolds for CNS targeted leads. 130
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration 129
Anticoagulant activity of new glycoconjugated inhibitors Of factor Xa and thrombin 129
Microfluidic pervaporation of ethanol from radiopharmaceutical formulations 129
(EN) GALLOYL BENZAMIDE-BASED COMPOUNDS AS JNK MODULATORS (FR) COMPOSES A BASE DE GALLOYL BENZAMIDE UTILISES EN TANT QUE MODULATEURS DE JNK 129
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 126
Determination of Lipophilicity and Hydrogen-bond Donor Acidity of Bioactive Sulphonyl-containing Compounds by Reversed-phase HPLC and Centrifugal Partition Chromatography and their Application to Structure-activity Relations 125
Lipophilicity Measurements of Benzenesulfonamide Inhibitors of Carbonic Anhydrase by Reversed-phase HPLC 124
AZEPINO [4,3-b]INDOLE DERIVATIVES AS SELECTIVE INHIBITORS OF HUMAN BUTYRYLCHOLINESTERASE WITH PROTECTIVE EFFECTS AGAINST NMDA-INDUCED NEUROTOXICITY 124
Pyrrolo(3,2-c)pyridine derivatives as inhibitors of platelet aggregation 123
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase 122
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 122
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 121
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors 120
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9 118
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor. 115
Inhibiting Aβ1-40 in vitro aggregation by glycine-based molecular tongs: rational design and mechanistic implications 113
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 112
An improved method for the biological evaluation of polyphenol derivatives as potential inhibitors of aβ(1–40) aggregation 112
Benzenesulfonamide inhibitors of carbonic anhydrase: study of their hydrophobicity by RPLC. 111
Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 110
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease 109
Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams 108
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 108
Synthesis and biological evaluation of arylhydrazone derivatives of indoles and indolin-2-ones as b-amyloid aggregation inhibitors 107
The effect of Thapsia essential oils on bile composition in rats 106
Design, synthesis and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors 106
Enantiomeric Resolution of Sulfoxides on a DACH-DNB Chiral Stationary Phase: a Quantitative Structure-Enantioselective Retention Relationship (QSERR) Study 106
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 105
Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded gucocorticoid after aerosolization in mice 105
Bicyclic dilactam peptides and N-substituted derivatives of cyclic aminoacids as new inhibitors of amyloidogenesis 104
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 104
Studio dell’Idrolisi Chimica e Plasmatica di Aril-nipecotati ad Attività Gaba-mimetica Attraverso Analisi Regressionale 103
Estimation of the Binding Free Energy by Linear Interaction Energy Models 103
New N-arylmethyl derivatives of some cyclic amino acids and new peptidomimetics: synthesis and inhibition activity of insulin amyloid formation 102
Teicoplanin-based enantiomeric separations in CZE using a partial filling technique 100
Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides 100
Development and analytical characterization of vitamin(s)-loaded chitosan nanoparticles for potential food packaging applications 97
Synthesis and anticonvulsant activity of some 1,2,3,3a-tetrahydropyrrolo[2,1-b]-benzothiazol-, -thiazol- or -oxazol-1-ones in rodents. 97
Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein. 96
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 95
Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors 95
Solid Phase Synthesis of Safinamide and Analogues as Potent and Selective MAO-B Inhibitors 94
Isatin 3-arylhydrazones: from inhibitors of amyloidogenesis to multitarget agents with potential in Alzheimer’s disease. 94
Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships 93
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 93
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 92
Direct chromatographic resolution of carnitine and O-acylcarnitine enantiomers on a teicoplanin-bonded chiral stationary phase 92
Oxazolidinone Amide Antibiotics 91
Ionization behaviour and tautomerism-dependent lipophilicity of pyridine-2(1H)-one cardiotonic agents 90
Effect of Thapsia essential oils on bile composition in rats 89
Derivatives of annulated tetrahydroazocines and tetrahydroazonines as cholinesterase inhibitors 88
Inhibition of uptake of [3H] dopamine into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 86
New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia 86
Insight into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 85
Thermodynamic Parameters, X-ray Structure, and QSAR Studies of Condensed Diazines as MAO Inhibitors 84
Antiplatelet activity of nipecotic acid derivatives 84
Application of a chiral stationary phase containing the glycopeptida antibiotic A-40,926 in the direct chromatographic resolution of B-amino acids 83
L'ISRP nella determinazione diretta di aril nipecotati in siero. 83
Coumarin as a versatile scaffold to selectively target biologically relevant cytochrome P450 enzymes: aromatase, steroid 11β-hydroxylase and aldosterone synthase 83
Synthesis and Pharmacological Evaluation of Perhydropyrrolo[3,4-c]pyridine Derivatives 82
Synthesis and Biological Evaluation of Dantrolene-Like Hydrazide and Hydrazone Analogues as Multitarget Agents for Neurodegenerative Diseases 82
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of PD 81
Totale 14.133
Categoria #
all - tutte 62.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021943 0 0 0 0 0 61 136 96 124 228 153 145
2021/20221.146 58 154 24 50 35 65 61 44 72 114 191 278
2022/20231.976 307 202 121 172 312 210 21 234 308 22 40 27
2023/2024755 54 113 40 94 58 146 33 27 30 22 20 118
2024/20252.414 77 57 229 110 61 170 211 221 133 104 332 709
2025/20264.361 710 546 1.681 628 543 253 0 0 0 0 0 0
Totale 17.493